Your browser is no longer supported. Please, upgrade your browser.
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E31.24 EPS (ttm)6.11 Insider Own11.70% Shs Outstand907.20M Perf Week14.64%
Market Cap178.58B Forward P/E23.28 EPS next Y8.19 Insider Trans-0.40% Shs Float744.27M Perf Month13.94%
Income5.57B PEG2.24 EPS next Q2.35 Inst Own79.20% Short Float0.70% Perf Quarter29.97%
Sales23.21B P/S7.69 EPS this Y54.10% Inst Trans1.53% Short Ratio1.22 Perf Half Y14.95%
Book/sh5.32 P/B35.86 EPS next Y8.92% ROA13.40% Target Price185.88 Perf Year34.89%
Cash/sh3.88 P/C49.19 EPS next 5Y13.97% ROE152.60% 52W Range117.06 - 189.30 Perf YTD12.99%
Dividend3.40 P/FCF64.14 EPS past 5Y17.40% ROI24.60% 52W High0.78% Beta0.34
Dividend %1.78% Quick Ratio1.10 Sales past 5Y2.60% Gross Margin78.30% 52W Low62.97% ATR5.66
Employees33625 Current Ratio1.40 Sales Q/Q4.80% Oper. Margin23.80% RSI (14)73.55 Volatility3.50% 2.39%
OptionableYes Debt/Eq3.51 EPS Q/Q-2.90% Profit Margin24.00% Rel Volume1.55 Prev Close186.69
ShortableYes LT Debt/Eq3.38 EarningsJan 29 BMO Payout46.70% Avg Volume4.27M Price190.77
Recom2.20 SMA2011.63% SMA5021.91% SMA20024.29% Volume6,624,572 Change2.19%
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jan-19-21 06:30AM  
Jan-15-21 05:02PM  
08:14AM  
06:45AM  
Jan-14-21 03:29PM  
12:28PM  
06:45AM  
Jan-13-21 04:26PM  
09:35AM  
02:41AM  
Jan-12-21 03:10PM  
10:25AM  
09:32AM  
03:37AM  
Jan-11-21 05:00PM  
04:29PM  
04:19PM  
01:00PM  
12:59PM  
11:42AM  
10:24AM  
09:45AM  
09:44AM  
09:00AM  
08:56AM  
08:55AM  
08:15AM  
08:00AM  
07:22AM  
06:30AM  
Jan-08-21 09:00AM  
Jan-07-21 11:05AM  
Jan-05-21 05:50PM  
04:02PM  
10:05AM  
08:17AM  
06:00AM  
Jan-04-21 03:30PM  
10:18AM  
Jan-03-21 04:37AM  
Dec-30-20 11:34AM  
09:28AM  
Dec-29-20 05:50PM  
09:10AM  
Dec-28-20 04:01PM  
Dec-23-20 05:45PM  
Dec-22-20 03:34PM  
01:27PM  
Dec-21-20 09:00AM  
06:27AM  
Dec-19-20 07:00AM  
Dec-18-20 05:00PM  
02:14PM  
07:34AM  
Dec-17-20 05:45PM  
10:04AM  
10:00AM  
Dec-16-20 08:21PM  
03:30PM  
02:56PM  
02:05PM  
12:37PM  
10:29AM  
09:37AM  
07:57AM  
Dec-15-20 05:39PM  
04:36PM  
04:25PM  
04:18PM  
03:15PM  
02:37PM  
12:31PM  
11:45AM  
11:20AM  
11:00AM  
10:49AM  
10:38AM  
10:19AM  
10:04AM  
09:58AM  
09:53AM  
09:51AM  
09:48AM  
09:44AM  
08:36AM  
07:53AM  
06:43AM  
06:30AM  
06:25AM  
06:15AM  
Dec-14-20 07:18PM  
04:12PM  
04:05PM  
11:05AM  
Dec-13-20 03:00PM  
Dec-11-20 05:45PM  
04:35PM  
03:04PM  
02:01PM  
11:00AM  
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; and Sermonix Pharmaceuticals Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM
Smiley Joshua LSVP and CFOOct 01Option Exercise0.007,947044,918Oct 05 12:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMSep 08Sale151.015,000755,05023,580Sep 10 04:25 PM
Mason Michael BSr. VP & Pres., Lilly DiabetesSep 01Option Exercise0.006,244021,279Sep 02 05:04 PM
Fry Stephen FSVP, HR & DiversityAug 17Sale150.647,2041,085,211100,211Aug 18 03:31 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale169.6912,9612,199,392111,132,343Jul 10 02:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJul 09Sale170.0011,0001,870,00018,646Jul 13 01:43 PM
LILLY ENDOWMENT INC10% OwnerJul 07Sale167.29210,00035,131,799111,145,304Jul 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale166.99205,00034,232,086111,379,612Jul 07 02:27 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,46805,424Jul 06 04:50 PM
LILLY ENDOWMENT INC10% OwnerJun 30Sale163.20166,83227,227,760111,560,304Jul 01 11:17 AM
LILLY ENDOWMENT INC10% OwnerJun 29Sale163.3911,4311,867,760111,727,136Jun 30 03:12 PM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jul 01 09:55 AM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jun 30 02:48 PM
LILLY ENDOWMENT INC10% OwnerJun 18Sale161.5453,7708,686,046111,770,304Jun 19 02:21 PM
LILLY ENDOWMENT INC10% OwnerJun 17Sale161.38161,23026,019,469111,824,074Jun 18 05:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 16Sale162.9417,0002,770,00029,646Jun 18 09:36 AM
LILLY ENDOWMENT INC10% OwnerJun 16Sale162.92212,33734,593,145111,985,304Jun 17 03:13 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 05Sale150.0010,0001,500,00046,646Jun 09 04:52 PM
LILLY ENDOWMENT INC10% OwnerApr 27Sale163.6012,6632,071,715112,197,641Apr 28 12:21 PM
LILLY ENDOWMENT INC10% OwnerApr 24Sale162.47220,00035,743,218112,210,304Apr 27 02:36 PM
LILLY ENDOWMENT INC10% OwnerApr 23Sale160.12230,00036,826,587112,430,304Apr 27 10:39 AM
Shah Aarti S.SVP & CIOApr 14Sale150.002,000300,00019,087Apr 16 11:23 AM
LILLY ENDOWMENT INC10% OwnerApr 09Sale145.42230,00033,445,542112,660,304Apr 13 02:43 PM
LILLY ENDOWMENT INC10% OwnerApr 07Sale143.20172,31524,676,281112,890,304Apr 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerApr 06Sale142.7315,9622,278,322113,062,619Apr 07 11:40 AM
LILLY ENDOWMENT INC10% OwnerApr 03Sale143.1926,7233,826,493113,078,581Apr 06 02:42 PM
LILLY ENDOWMENT INC10% OwnerApr 02Sale140.78166,03823,374,654113,105,304Apr 03 12:42 PM
LILLY ENDOWMENT INC10% OwnerMar 31Sale140.0738,9625,457,474113,271,342Apr 01 01:47 PM
LILLY ENDOWMENT INC10% OwnerMar 30Sale139.11210,00029,213,559113,310,304Mar 31 04:03 PM
Fry Stephen FSVP, HR & DiversityMar 30Sale134.3014,6571,968,434107,415Mar 31 11:50 AM
Norton JohnaSenior VP, Global QualityMar 16Sale131.004,727619,23717,674Mar 18 10:44 AM
O'Neill MylesSVP & Pres., Mfg. OperationsMar 04Sale140.1525,0003,503,7508,469Mar 06 10:46 AM
Zakrowski Donald AChief Accounting OfficerMar 02Sale128.003,700473,6004,740Mar 03 03:27 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.00970162Feb 18 02:57 PM
LILLY ENDOWMENT INC10% OwnerFeb 05Sale146.61200,00029,321,808113,520,304Feb 06 02:27 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,317045,623Feb 04 03:59 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0069,3500226,755Feb 04 03:54 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0013,0550113,266Feb 04 03:47 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.004,896025,166Feb 04 03:44 PM